Close Cookie Popup

Cookie Preferences

By clicking “Accept All”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage and assist in our marketing efforts as outlined in our cookie policy.

NLC was named the Number 1 Most Active Early Stage Investor in Healthcare in Europe by Financial Times’ Sifted

https://nlc-health.webflow.io/news/nlc-was-named-the-number-1-most-active-early-stage-investor-in-healthcare-in-europe-by-financial-times-sifted

By

Nanna Liebregt

May 2024

•

5 min read

By

Nanna Liebregt

May 2024

•

5 min read

Read article on external website

Share this post

News

Insights

From invention to impact: Inside NLC’s venture creation and selection process

From invention to impact: Inside NLC’s venture creation and selection process

From invention to impact: Inside NLC’s venture creation and selection process

Driving return and impact: Inside The NLC Health Impact Fund’s vision and strategy

Driving return and impact: Inside The NLC Health Impact Fund’s vision and strategy

Driving return and impact: Inside The NLC Health Impact Fund’s vision and strategy

The Future of Healthcare: A conversation with Dr. Fenna Heyning on reinventing hospitals for the digital age

The Future of Healthcare: A conversation with Dr. Fenna Heyning on reinventing hospitals for the digital age

The Future of Healthcare: A conversation with Dr. Fenna Heyning on reinventing hospitals for the digital age

Introducing DiaphOne Therapeutics: Developing small molecule antagonists

Venture launches

Introducing DiaphOne Therapeutics: Developing small molecule antagonists

Venture launches

Introducing DiaphOne Therapeutics: Developing small molecule antagonists

The power of additionality: Why impact investing should focus on building companies that otherwise wouldn’t exist

The power of additionality: Why impact investing should focus on building companies that otherwise wouldn’t exist

The power of additionality: Why impact investing should focus on building companies that otherwise wouldn’t exist

Innovation and collaboration is the cure to solving the healthcare crisis

Innovation and collaboration is the cure to solving the healthcare crisis

Innovation and collaboration is the cure to solving the healthcare crisis

Derisking early-stage investments to solve global healthcare challenges

Derisking early-stage investments to solve global healthcare challenges

Derisking early-stage investments to solve global healthcare challenges

NLC & HMG launch the Global Open Challenge!

NLC & HMG launch the Global Open Challenge!

NLC & HMG launch the Global Open Challenge!

NLC Health Ventures and HMG are announcing partnership to accelerate global health tech innovations

NLC Health Ventures and HMG are announcing partnership to accelerate global health tech innovations

NLC Health Ventures and HMG are announcing partnership to accelerate global health tech innovations

Nina Rijnders: Impact investing for philanthropic fund (In Dutch)

Nina Rijnders: Impact investing for philanthropic fund (In Dutch)

Nina Rijnders: Impact investing for philanthropic fund (In Dutch)

SERDA Therapeutics Announces Completion of First Phase 1 Clinical Study of SN514

SERDA Therapeutics Announces Completion of First Phase 1 Clinical Study of SN514

SERDA Therapeutics Announces Completion of First Phase 1 Clinical Study of SN514

Introducing Exolvo: NLC Health Ventures launches new early-stage drug delivery company

Venture launches

Introducing Exolvo: NLC Health Ventures launches new early-stage drug delivery company

Venture launches

Introducing Exolvo: NLC Health Ventures launches new early-stage drug delivery company

Dutch health insurer VGZ invests in NLC Health Ventures

Dutch health insurer VGZ invests in NLC Health Ventures

Dutch health insurer VGZ invests in NLC Health Ventures

NLC venture Altach secures €1.2 million investment to transform treatments for cartilage injuries

NLC venture Altach secures €1.2 million investment to transform treatments for cartilage injuries

NLC venture Altach secures €1.2 million investment to transform treatments for cartilage injuries

NLC completes first close of €100 million health impact fund

NLC completes first close of €100 million health impact fund

NLC completes first close of €100 million health impact fund

AI Healthtech start-up MindAffect raises €1.1 million to transform hearing diagnostics

AI Healthtech start-up MindAffect raises €1.1 million to transform hearing diagnostics

AI Healthtech start-up MindAffect raises €1.1 million to transform hearing diagnostics

IPD secures funding of €2.1 million to initiate its first-in-human trials for prosthetic joint infections

IPD secures funding of €2.1 million to initiate its first-in-human trials for prosthetic joint infections

IPD secures funding of €2.1 million to initiate its first-in-human trials for prosthetic joint infections

Introducing Aerion Bioscience: A new era of cancer screening

Venture launches

Introducing Aerion Bioscience: A new era of cancer screening

Venture launches

Introducing Aerion Bioscience: A new era of cancer screening

CUIP and NLC Health Ventures signed a MoU to bring cutting-edge innovations to life

CUIP and NLC Health Ventures signed a MoU to bring cutting-edge innovations to life

CUIP and NLC Health Ventures signed a MoU to bring cutting-edge innovations to life

POROUS wins innovation award

POROUS wins innovation award

POROUS wins innovation award